{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T12:05:27Z","timestamp":1771848327471,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["1-11-CT-35"],"award-info":[{"award-number":["1-11-CT-35"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["1-14-TS-28"],"award-info":[{"award-number":["1-14-TS-28"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK096283-01"],"award-info":[{"award-number":["R01 DK096283-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["P2BEP3_175289"],"award-info":[{"award-number":["P2BEP3_175289"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s40618-020-01430-2","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T15:03:34Z","timestamp":1615302214000},"page":"2123-2130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Using metabolic markers to identify insulin resistance in premenopausal women with and without polycystic ovary syndrome"],"prefix":"10.1007","volume":"44","author":[{"given":"M. R.","family":"Blum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Popat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. A.","family":"Cataldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4829-8649","authenticated-orcid":false,"given":"T. L.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"issue":"27","key":"1430_CR1","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1056\/NEJM199312303292703","volume":"329","author":"S Lillioja","year":"1993","unstructured":"Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E et al (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329(27):1988\u20131992","journal-title":"N Engl J Med"},{"issue":"15","key":"1430_CR2","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1056\/nejm199604113341504","volume":"334","author":"J-P Despr\u00e9s","year":"1996","unstructured":"Despr\u00e9s J-P, Lamarche B, Mauri\u00e8ge P, Cantin B, Dagenais GR, Moorjani S et al (1996) Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334(15):952\u2013958. https:\/\/doi.org\/10.1056\/nejm199604113341504","journal-title":"N Engl J Med"},{"issue":"8","key":"1430_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/s0026-0495(99)90195-6","volume":"48","author":"I Zavaroni","year":"1999","unstructured":"Zavaroni I, Bonini L, Gasparini P, Barilli AL, Zuccarelli A, Dall\u2019Aglio E et al (1999) Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. Metabolism 48(8):989\u2013994. https:\/\/doi.org\/10.1016\/s0026-0495(99)90195-6","journal-title":"Metabolism"},{"issue":"8","key":"1430_CR4","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1210\/jcem.83.8.5005","volume":"83","author":"J Yip","year":"1998","unstructured":"Yip J, Facchini FS, Reaven GM (1998) Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 83(8):2773\u20132776","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1430_CR5","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1210\/jcem.86.8.7763","volume":"86","author":"FS Facchini","year":"2001","unstructured":"Facchini FS, Hua N, Abbasi F, Reaven GM (2001) Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 86(8):3574\u20133578","journal-title":"J Clin Endocrinol Metab"},{"key":"1430_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59259-716-1_19","author":"JE Nestler","year":"1999","unstructured":"Nestler JE (1999) Insulin resistance effects on sex hormones and ovulation in the polycystic ovary syndrome. Insulin Resist. https:\/\/doi.org\/10.1007\/978-1-59259-716-1_19","journal-title":"Insulin Resist"},{"issue":"2","key":"1430_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1055\/s-0030-1270450","volume":"43","author":"LW Cho","year":"2011","unstructured":"Cho LW, Kilpatrick ES, Keevil BG, Jayagopal V, Coady AM, Rigby AS et al (2011) Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controls. Horm Metab Res 43(2):141\u2013145","journal-title":"Horm Metab Res"},{"issue":"1","key":"1430_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3121\/cmr.2.1.13","volume":"2","author":"MT Sheehan","year":"2004","unstructured":"Sheehan MT (2004) Polycystic ovarian syndrome: diagnosis and management. Clin Med Res 2(1):13\u201327","journal-title":"Clin Med Res"},{"issue":"1","key":"1430_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1210\/jcem-72-1-83","volume":"72","author":"JE Nestler","year":"1991","unstructured":"Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS et al (1991) A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72(1):83\u201389","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1430_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0015-0282(99)00468-9","volume":"73","author":"KJ Mather","year":"2000","unstructured":"Mather KJ, Kwan F, Corenblum B (2000) Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil Steril 73(1):150\u2013156","journal-title":"Fertil Steril"},{"issue":"1","key":"1430_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.numecd.2018.09.014","volume":"29","author":"T McLaughlin","year":"2019","unstructured":"McLaughlin T, Abbasi F, Lamendola C, Yee G, Carter S, Cushman SW (2019) Dietary weight loss in insulin-resistant non-obese humans: metabolic benefits and relationship to adipose cell size. Nutr Metab Cardiovasc Dis 29(1):62\u201368. https:\/\/doi.org\/10.1016\/j.numecd.2018.09.014","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"1430_CR12","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/ajcn\/84.4.813","volume":"84","author":"T McLaughlin","year":"2006","unstructured":"McLaughlin T, Carter S, Lamendola C, Abbasi F, Yee G, Schaaf P et al (2006) Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults. Am J Clin Nutr 84(4):813\u2013821. https:\/\/doi.org\/10.1093\/ajcn\/84.4.813","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"1430_CR13","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1053\/meta.2001.24210","volume":"50","author":"T McLaughlin","year":"2001","unstructured":"McLaughlin T, Abbasi F, Kim HS, Lamendola C, Schaaf P, Reaven G (2001) Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. Metabolism 50(7):795\u2013800","journal-title":"Metabolism"},{"issue":"6","key":"1430_CR14","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/ijo.2015.18","volume":"39","author":"D Eriksson-Hogling","year":"2015","unstructured":"Eriksson-Hogling D, Andersson DP, B\u00e4ckdahl J, Hoffstedt J, R\u00f6ssner S, Thorell A et al (2015) Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss. Int J Obes 39(6):893\u2013898. https:\/\/doi.org\/10.1038\/ijo.2015.18","journal-title":"Int J Obes"},{"issue":"3","key":"1430_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrendo.2016.162","volume":"13","author":"L Sylow","year":"2017","unstructured":"Sylow L, Kleinert M, Richter EA, Jensen TE (2017) Exercise-stimulated glucose uptake\u2014regulation and implications for glycaemic control. Nat Rev Endocrinol. 13(3):133\u2013148. https:\/\/doi.org\/10.1038\/nrendo.2016.162","journal-title":"Nat Rev Endocrinol."},{"issue":"4","key":"1430_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0026-0495(99)90113-0","volume":"48","author":"CJ Glueck","year":"1999","unstructured":"Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L (1999) Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome. Metabolism 48(4):511\u2013519","journal-title":"Metabolism"},{"issue":"1","key":"1430_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/humrep\/dei289","volume":"21","author":"NA Cataldo","year":"2006","unstructured":"Cataldo NA, Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC et al (2006) Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome. Hum Reprod 21(1):109\u2013120","journal-title":"Hum Reprod"},{"issue":"9","key":"1430_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/00006254-200209000-00017","volume":"57","author":"ES Ford","year":"2002","unstructured":"Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among us adults: findings from the Third National Health and Nutrition Examination Survey. Obstetr Gynecol Surv 57(9):576\u2013577. https:\/\/doi.org\/10.1097\/00006254-200209000-00017","journal-title":"Obstetr Gynecol Surv"},{"issue":"10","key":"1430_CR19","doi-asserted-by":"publisher","first-page":"802","DOI":"10.7326\/0003-4819-139-10-200311180-00007","volume":"139","author":"T McLaughlin","year":"2003","unstructured":"McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G (2003) Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139(10):802\u2013809","journal-title":"Ann Intern Med"},{"issue":"7897","key":"1430_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/s0140-6736(75)92376-4","volume":"305","author":"GJ Miller","year":"1975","unstructured":"Miller GJ, Miller NE (1975) Plasma-high-density-lipoprotein concentration and development of isch\u00e6mic heart-disease. Lancet 305(7897):16\u201319. https:\/\/doi.org\/10.1016\/s0140-6736(75)92376-4","journal-title":"Lancet"},{"issue":"20","key":"1430_CR21","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1001\/jama.256.20.2835","volume":"256","author":"WP Castelli","year":"1986","unstructured":"Castelli WP (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256(20):2835\u20132838. https:\/\/doi.org\/10.1001\/jama.256.20.2835","journal-title":"JAMA"},{"issue":"1","key":"1430_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115483","volume":"131","author":"DR Jacobs Jr","year":"1990","unstructured":"Jacobs DR Jr, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA (1990) High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 131(1):32\u201347","journal-title":"Am J Epidemiol"},{"issue":"2","key":"1430_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/oxfordjournals.aje.a115130","volume":"129","author":"MA Austin","year":"1989","unstructured":"Austin MA (1989) Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. Am J Epidemiol 129(2):249\u2013259","journal-title":"Am J Epidemiol"},{"issue":"6","key":"1430_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.numecd.2008.09.003","volume":"19","author":"F Hadaegh","year":"2009","unstructured":"Hadaegh F, Khalili D, Ghasemi A, Tohidi M, Sheikholeslami F, Azizi F (2009) Triglyceride\/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis 19(6):401\u2013408. https:\/\/doi.org\/10.1016\/j.numecd.2008.09.003","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"1430_CR25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/joim.12036","volume":"273","author":"MR Salazar","year":"2013","unstructured":"Salazar MR, Carbajal HA, Espeche WG, Aizpur\u00faa M, Leiva Sisnieguez CE, March CE et al (2013) Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride\/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria. J Intern Med 273(6):595\u2013601","journal-title":"J Intern Med"},{"issue":"8","key":"1430_CR26","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/oby.2009.446","volume":"18","author":"T Marotta","year":"2010","unstructured":"Marotta T, Russo BF, Ferrara LA (2010) Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients. Obesity 18(8):1608\u20131613","journal-title":"Obesity"},{"issue":"11","key":"1430_CR27","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/aje\/kwp043","volume":"169","author":"CA Derby","year":"2009","unstructured":"Derby CA, Crawford SL, Pasternak RC, Sowers M, Sternfeld B, Matthews KA (2009) Lipid changes during the menopause transition in relation to age and weight: the Study of Women\u2019s Health Across the Nation. Am J Epidemiol 169(11):1352\u20131361","journal-title":"Am J Epidemiol"},{"issue":"10","key":"1430_CR28","doi-asserted-by":"publisher","first-page":"735","DOI":"10.7326\/L15-5093-2","volume":"162","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KGM (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD). Ann Intern Med 162(10):735","journal-title":"Ann Intern Med"},{"key":"1430_CR29","first-page":"377","volume-title":"Polycystic ovary syndrome","author":"JK Zawadski","year":"1992","unstructured":"Zawadski JK, Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam GR (eds) Polycystic ovary syndrome. Blackwell Scientific, Boston, pp 377\u2013384"},{"issue":"2","key":"1430_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2337\/diacare.23.2.171","volume":"23","author":"H Yeni-Komshian","year":"2000","unstructured":"Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM (2000) Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 23(2):171\u2013175","journal-title":"Diabetes Care"},{"issue":"8","key":"1430_CR31","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/BF00404344","volume":"37","author":"D Pei","year":"1994","unstructured":"Pei D, Jones CN, Bhargava R, Chen YD, Reaven GM (1994) Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 37(8):843\u2013845","journal-title":"Diabetologia"},{"issue":"12","key":"1430_CR32","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1172\/jci106433","volume":"49","author":"S-W Shen","year":"1970","unstructured":"Shen S-W, Reaven GM, Farquhar JW (1970) Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Investig. 49(12):2151\u20132160. https:\/\/doi.org\/10.1172\/jci106433","journal-title":"J Clin Investig."},{"issue":"5","key":"1430_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2337\/diabetes.30.5.387","volume":"30","author":"MS Greenfield","year":"1981","unstructured":"Greenfield MS, Doberne L, Kraemer F, Tobey T, Reaven G (1981) Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 30(5):387\u2013392. https:\/\/doi.org\/10.2337\/diabetes.30.5.387","journal-title":"Diabetes"},{"issue":"6","key":"1430_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499\u2013502","journal-title":"Clin Chem"},{"issue":"1","key":"1430_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0022-1759(95)00121-P","volume":"185","author":"M Greiner","year":"1995","unstructured":"Greiner M, Sohr D, G\u00f6bel P (1995) A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests. J Immunol Methods 185(1):123\u2013132","journal-title":"J Immunol Methods"},{"issue":"5","key":"1430_CR36","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","volume":"83","author":"C Deugarte","year":"2005","unstructured":"Deugarte C, Bartolucci A, Azziz R (2005) Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 83(5):1454\u20131460","journal-title":"Fertil Steril"},{"issue":"3","key":"1430_CR37","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","volume":"148","author":"JA Hanley","year":"1983","unstructured":"Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148(3):839\u2013843","journal-title":"Radiology"},{"key":"1430_CR38","doi-asserted-by":"crossref","unstructured":"Thiele C (2018) Cutpointr: Determine and Evaluate Optimal Cutpoints in Binary Classification Tasks. https:\/\/CRAN.R-project.org\/package=cutpointr.","DOI":"10.32614\/CRAN.package.cutpointr"},{"issue":"1","key":"1430_CR39","doi-asserted-by":"publisher","first-page":"e000811","DOI":"10.1136\/bmjdrc-2019-000811","volume":"8","author":"D Zheng","year":"2020","unstructured":"Zheng D, Li H, Ai F, Sun F, Singh M, Cao X, Jiang J, He Y, Tang Z, Guo X (2020) Association between the triglyceride to high-density lipoprotein cholesterol ratio and the risk of type 2 diabetes mellitus among Chinese elderly: the Beijing Longitudinal Study of Aging. BMJ Open Diabetes Res Care 8(1):e000811","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"8","key":"1430_CR40","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.2337\/dc10-2234","volume":"34","author":"C Giannini","year":"2011","unstructured":"Giannini C, Santoro N, Caprio S, Kim G, Lartaud D, Shaw M, Pierpont B, Weiss R (2011) The Triglyceride-to-HDL Cholesterol Ratio Association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care 34(8):1869\u20131874","journal-title":"Diabetes Care"},{"issue":"5","key":"1430_CR41","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.numecd.2015.01.012","volume":"25","author":"P Di Bonito","year":"2015","unstructured":"Di Bonito P, Valerio G, Grugni G et al (2015) Comparison of non-HDL-cholesterol versus triglycerides-to-HDL-cholesterol ratio in relation to cardiometabolic risk factors and preclinical organ damage in overweight\/obese children: The CARITALY study. Nutr Metab Cardiavasc Dis 25(5):489\u2013494","journal-title":"Nutr Metab Cardiavasc Dis"},{"issue":"3","key":"1430_CR42","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2265.1993.tb02376.x","volume":"39","author":"S Robinson","year":"1993","unstructured":"Robinson S, Kiddy D, Gelding SV, Willis D, Niththyananthan R, Bush A et al (1993) The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol 39(3):351\u2013355","journal-title":"Clin Endocrinol"},{"issue":"4","key":"1430_CR43","doi-asserted-by":"publisher","first-page":"E628","DOI":"10.1210\/jc.2012-3908","volume":"98","author":"P Moghetti","year":"2013","unstructured":"Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman J-M et al (2013) Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab 98(4):E628\u2013E637","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1430_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijgo.2015.09.008","volume":"133","author":"HE Ellakwa","year":"2016","unstructured":"Ellakwa HE, Sanad ZF, Hamza HA, Emara MA, Elsayed MA (2016) Predictors of patient responses to ovulation induction with clomiphene citrate in patients with polycystic ovary syndrome experiencing infertility. Int J Gynaecol Obstet 133(1):59\u201363","journal-title":"Int J Gynaecol Obstet"},{"issue":"7","key":"1430_CR45","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1210\/jc.2008-0115","volume":"93","author":"K Elkind-Hirsch","year":"2008","unstructured":"Elkind-Hirsch K, Marrioneaux O, Bhushan M, Vernor D, Bhushan R (2008) Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 93(7):2670\u20132678","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1430_CR46","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.4158\/ep15748.dscpt2","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E (2015) American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and Pcos Society Disease State clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2014part 2. Endocr Pract 21(12):1415\u20131426. https:\/\/doi.org\/10.4158\/ep15748.dscpt2","journal-title":"Endocr Pract"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01430-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01430-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01430-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T18:32:24Z","timestamp":1724610744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01430-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1430"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01430-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,9]]},"assertion":[{"value":"13 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}